|   
  |       2013.1.8 Treatment-Free  |       2013.6.17 Treating (Low Rd)  |       2014.2.3 Treating (Low Rd-CAM)  |       2014.4.7 Treatment-Free  |       2014.6.2 Treating (Low Rd-CAM)  |       (Normal Range)  |    
|   IL-1β (pg/mL)  |       <0.125  |       <0.125  |       0.27  |       <0.125  |       
  |       (≤0.928)  |    
|   IL-2 (pg/mL)  |       <15.6  |       <15.6  |       <15.6  |       <15.6  |       <15.6  |       (<15.6)  |    
|   IL-4 (pg/mL)  |       
  |       
  |       
  |       <0.25  |       
  |       (<0.25)  |    
|   IL-5 (pg/mL)  |       <3.9  |       
  |       
  |       <3.9  |       
  |       (<3.9)  |    
|   IL-6 (pg/mL)  |       1.27  |       1.49  |       7.33 ↑↑  |       2.52↑  |       10.4 ↑↑  |       (≤2.41)  |    
|   IL-8 (pg/mL)  |       
  |       
  |       
  |       <8.0  |       
  |       (<8.0)  |    
|   IL-10 (pg/mL)  |       <0.5  |       
  |       
  |       <0.5  |       
  |       (<7.05)  |    
|   IL-12 (pg/mL)  |       <0.78  |       
  |       
  |       0.78  |       1.86  |       (≤3.15)  |    
|   TNF-α (pg/mL)  |       <0.55  |       <0.55  |       2.19 ↑  |       1.07  |       1.48  |       (≤1.79)  |    
|   TGF-β1 (pg/mL)  |       
  |       
  |       
  |       1.35  |       2.27 ↑  |       (0.89 - 1.80)  |    
|   IFN-γ (pg/mL)  |       <1.56  |       <1.56  |       
  |       6.94  |       5.59  |       (≤20.6)  |